NILSSON HENRIK: Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix. FORWARD PHARMA, Stahr Pia, July 15, 2010: WO/2010/079222 (12 worldwide citation)

A pharmaceutical formulation comprising an erosion matrix comprising one or more fumaric acid esters as well as one or more rate-controlling agents, wherein erosion of said erosion matrix permits controlled release of said fumaric acid ester(s).

LU GUANG: Data flow mobility. INTERDIGITAL PATENT HOLDINGS, Mcnamara Joseph E, July 15, 2010: WO/2010/080966 (12 worldwide citation)

A wireless transmit/receive unit (WTRU) may communicate using a data flow that is defined according to flow identification information (FII). The WTRU may participate in the transfer of the data flow between access networks of diverse radio access technologies. The WTRU may communicate with a mobili ...

NAKAMURA KATSUSHIGE: 立体内視鏡 (JA), Stereo-endoscope (EN). MITAKA KOHKI, Miyoshi Hidekazu, July 15, 2010: WO/2010/079817 (12 worldwide citation)

A pair of left and right rod lenses (19) is disposed in the insertion part (10) of a stereo-endoscope (3), and an objective optical system (18), consisting of a stationary lens (22) and a moveable lens (23), is disposed at the tip thereof. The moveable lens (23) is moved by a motor (24) to change th ...

HU DEAN: Reduced pressure therapy of the sacral region. SPIRACUR, Wu Walter, July 15, 2010: WO/2010/080907 (12 worldwide citation)

Reduced pressure wound therapy is performed on a sacral region of a patient using an adhesive dressing comprising a flexible planar layer and a non-planar fold-sealing region configured to seal to the intergluteal cleft of a patient. The fold-sealing region is located on an outer edge of the adhesiv ...

BIBA SCOTT I: Medication cabinetry. AMERISOURCEBERGEN CORPORATION, Morrow James G, July 15, 2010: WO/2010/080660 (12 worldwide citation)

An exemplary embodiment includes a cabinet having at least one drawer with selectable access for storing items, such as medications. A slidable cover with a first opening allows for closure and/or access to items in an interior of the drawer. The cabinet further includes an actuator coupled to the c ...

NANCHEN STEVE: Isoxazolines derivatives and their use as pesticide. Novartis, Liphardt Bernd, July 15, 2010: WO/2010/079077 (12 worldwide citation)

The invention relates to new pyrimidine compounds of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful in the control of parasites, in p ...

JOHNSON LESLIE S: Covalent diabodies and uses thereof. MACROGENICS, Auerbach Jeffrey I, July 15, 2010: WO/2010/080538 (12 worldwide citation)

The present invention is directed to diabody molecules and uses thereof in the treatment of a variety of diseases and disorders, including immunological disorders, infectious disease, intoxication and cancers. The diabody molecules of the invention comprise two polypeptide chains that associate to f ...

HARMON ALEXANDER M: Conditioned media and methods of making a conditioned media. ETHICON INCORPORATED, Finan Therese, July 15, 2010: WO/2010/080364 (12 worldwide citation)

A stable and scalable process is provided to manufacture reduced serum umbilical cord tissue-derived (UTC)-conditioned media. The method includes the culture of a UTC under reduced serum conditions. Subsequently, the UTC is washed and grown in serum-free basal media. After approximately 24 hours, th ...

Shalwitz Robert: Methods for treating vascular leak syndrome. AKEBIA THERAPEUTICS, Echler Richard S, July 15, 2010: WO/2010/081172 (11 worldwide citation)

Disclosed are methods for treating Vascular Leak Syndrome. Further disclosed are methods for treating vascular leakage due to inflammatory diseases, inter alia, sepsis, lupus, irritable bowel disease. Yet further disclosed are methods for treating renal cell carcinoma and melanoma. Still further dis ...

DHAWAN ISH KUMAR: Transaminase polypeptides. CODEXIS, Euk Charlie Oh, July 15, 2010: WO/2010/081053 (11 worldwide citation)

The present disclosure provides engineered transaminase enzymes having improved properties as compared to a naturally occurring wild-type transaminase enzyme. Also provided are polynucleotides encoding the engineered transaminase enzymes, host cells capable of expressing the engineered transaminase ...